| Name | Market Cap | Current Price | P/E Ratio | Revenue Growth 1Y | Net Margin | ROE | FCF Yield | Debt/Equity |
|---|---|---|---|---|---|---|---|---|
| AMWLAmerican Well Corporation | 70.09M | 4.76 | -0.34 | -1.81% | -42.8% | -42.43% | 0.03 | |
| TDOCTeladoc Health, Inc. | 1.16B | 6.53 | -1.11 | -1.26% | -8.84% | -16.06% | 24.41% | 1.06 |
| EUDAEUDA Health Holdings Limited | 69.19M | 1.83 | -3.89 | 8.22% | 5.17% |
| Dec 2015 | Dec 2016 | Dec 2017 | Dec 2018 | Dec 2019 | Dec 2020 | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales/Revenue | 77.38M | 123.16M | 233.28M | 417.91M | 553.31M | 1.09B | 2.03B | 2.41B | 2.6B | 2.57B |
| Revenue Growth % | 0.78% | 0.59% | 0.89% | 0.79% | 0.32% | 0.98% | 0.86% | 0.18% | 0.08% | -0.01% |
| Cost of Goods Sold | 21.04M | 31.97M | 61.62M | 128.74M | 184.47M | 390.83M | 650.26M | 743.99M | 760.03M | 751.27M |
| COGS % of Revenue | 0.27% | 0.26% | 0.26% | 0.31% | 0.33% | 0.36% | 0.32% | 0.31% | 0.29% | 0.29% |
| Gross Profit | 56.34M | 91.19M | 171.66M | 289.17M | 368.84M | 703.13M | 1.38B | 1.66B | 1.84B | 1.82B |
| Gross Margin % | 0.73% | 0.74% | 0.74% | 0.69% | 0.67% | 0.64% | 0.68% | 0.69% | 0.71% | 0.71% |
| Gross Profit Growth % | 0.68% | 0.62% | 0.88% | 0.68% | 0.28% | 0.91% | 0.97% | 0.2% | 0.11% | -0.01% |
| Operating Expenses | 112.13M | 153.85M | 247.05M | 360.03M | 449.28M | 1.21B | 1.65B | 15.32B | 2.09B | 2.84B |
| OpEx % of Revenue | 1.45% | 1.25% | 1.06% | 0.86% | 0.81% | 1.11% | 0.81% | 6.36% | 0.8% | 1.1% |
| Selling, General & Admin | 89.27M | 113.65M | 180.3M | 265.16M | 339.07M | 886.88M | 1.11B | 1.3B | 1.37B | 1.35B |
| SG&A % of Revenue | 1.15% | 0.92% | 0.77% | 0.63% | 0.61% | 0.81% | 0.54% | 0.54% | 0.53% | 0.52% |
| Research & Development | 14.21M | 21.82M | 34.46M | 54.37M | 64.64M | 164.94M | 311.88M | 333.63M | 348.52M | 307.27M |
| R&D % of Revenue | 0.18% | 0.18% | 0.15% | 0.13% | 0.12% | 0.15% | 0.15% | 0.14% | 0.13% | 0.12% |
| Other Operating Expenses | 8.64M | 18.39M | 32.29M | 40.49M | 45.57M | 157.73M | 230.88M | 13.68B | 375.12M | 1.19B |
| Operating Income | -55.78M | -62.66M | -75.39M | -70.85M | -80.44M | -506.42M | -265.63M | -13.65B | -248.55M | -1.02B |
| Operating Margin % | -0.72% | -0.51% | -0.32% | -0.17% | -0.15% | -0.46% | -0.13% | -5.67% | -0.1% | -0.4% |
| Operating Income Growth % | -2.68% | -0.12% | -0.2% | 0.06% | -0.14% | -5.3% | 0.48% | -50.4% | 0.98% | -3.11% |
| EBITDA | -50.92M | -54.39M | -56.3M | -35.25M | -41.49M | -442.73M | -58.06M | -13.44B | 5.56M | -780.38M |
| EBITDA Margin % | -0.66% | -0.44% | -0.24% | -0.08% | -0.07% | -0.4% | -0.03% | -5.59% | 0% | -0.3% |
| EBITDA Growth % | -2.97% | -0.07% | -0.04% | 0.37% | -0.18% | -9.67% | 0.87% | -230.55% | 1% | -141.33% |
| D&A (Non-Cash Add-back) | 4.86M | 8.27M | 19.09M | 35.6M | 38.95M | 63.69M | 207.57M | 209.93M | 254.11M | 240.51M |
| EBIT | -52M | -52.55M | -62.2M | -65.96M | -73.82M | -418.19M | -238.99M | -217.47M | -210.5M | -208.79M |
| Net Interest Income | -2.2M | -2.59M | -17.49M | -26.11M | -29.36M | -59.95M | -80.36M | -9.27M | 24.5M | 33.27M |
| Interest Income | 0 | 0 | 0 | 0 | 0 | 0 | 776K | 12.67M | 46.78M | 57.07M |
| Interest Expense | 2.2M | 2.59M | 17.49M | 26.11M | 29.36M | 59.95M | 81.14M | 21.94M | 22.28M | 23.8M |
| Other Income/Expense | -2.2M | -11.04M | -31.61M | -26.11M | -29.01M | -69.57M | -119.03M | -10.13M | 28.95M | 27.23M |
| Pretax Income | -57.98M | -73.71M | -107.01M | -96.97M | -109.45M | -575.99M | -384.66M | -13.66B | -219.61M | -993.65M |
| Pretax Margin % | -0.75% | -0.6% | -0.46% | -0.23% | -0.2% | -0.53% | -0.19% | -5.68% | -0.08% | -0.39% |
| Income Tax | 36K | 510K | -225K | 118K | -10.59M | -90.86M | 44.14M | -3.81M | 760K | 7.59M |
| Effective Tax Rate % | 1% | 1.01% | 1% | 1% | 0.9% | 0.84% | 1.11% | 1% | 1% | 1.01% |
| Net Income | -58.02M | -74.22M | -106.78M | -97.08M | -98.86M | -485.14M | -428.79M | -13.66B | -220.37M | -1B |
| Net Margin % | -0.75% | -0.6% | -0.46% | -0.23% | -0.18% | -0.44% | -0.21% | -5.68% | -0.08% | -0.39% |
| Net Income Growth % | -2.41% | -0.28% | -0.44% | 0.09% | -0.02% | -3.91% | 0.12% | -30.86% | 0.98% | -3.54% |
| Net Income (Continuing) | -58.02M | -74.22M | -106.78M | -97.08M | -98.86M | -485.14M | -428.79M | -13.66B | -220.37M | -1B |
| Discontinued Operations | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| EPS (Diluted) | -2.91 | -1.75 | -1.93 | -1.47 | -1.38 | -5.36 | -2.73 | -84.60 | -1.34 | -5.87 |
| EPS Growth % | -3.69% | 0.4% | -0.1% | 0.24% | 0.06% | -2.88% | 0.49% | -29.99% | 0.98% | -3.38% |
| EPS (Basic) | -2.91 | -1.75 | -1.93 | -1.47 | -1.38 | -5.36 | -2.73 | -84.60 | -1.36 | -5.87 |
| Diluted Shares Outstanding | 19.92M | 42.33M | 55.43M | 65.84M | 71.84M | 90.51M | 156.94M | 161.46M | 164.58M | 170.56M |
| Basic Shares Outstanding | 19.92M | 42.33M | 55.43M | 65.84M | 71.84M | 90.51M | 156.94M | 161.46M | 162.17M | 170.56M |
| Dividend Payout Ratio | - | - | - | - | - | - | - | - | - | - |
| Dec 2015 | Dec 2016 | Dec 2017 | Dec 2018 | Dec 2019 | Dec 2020 | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total Current Assets | 151.58M | 82.72M | 156.24M | 532.74M | 588M | 1.06B | 1.23B | 1.29B | 1.49B | 1.66B |
| Cash & Short-Term Investments | 137.35M | 65.81M | 122.31M | 478.53M | 517.06M | 786.57M | 896.02M | 918.18M | 1.12B | 1.3B |
| Cash Only | 55.07M | 50.02M | 42.82M | 423.99M | 514.35M | 733.32M | 893.48M | 918.18M | 1.12B | 1.3B |
| Short-Term Investments | 82.28M | 15.79M | 79.49M | 54.55M | 2.71M | 53.24M | 2.54M | 0 | 0 | 0 |
| Accounts Receivable | 12.13M | 13.81M | 27.09M | 43.57M | 56.95M | 169.28M | 190.12M | 235.65M | 230.06M | 223.96M |
| Days Sales Outstanding | 57.23 | 40.92 | 42.39 | 38.05 | 37.57 | 56.48 | 34.14 | 35.74 | 32.27 | 31.81 |
| Inventory | 0 | 0 | 0 | 0 | 0 | 56.5M | 73.08M | 56.34M | 29.51M | 38.14M |
| Days Inventory Outstanding | - | - | - | - | - | 52.76 | 41.02 | 27.64 | 14.17 | 18.53 |
| Other Current Assets | 2.1M | 0 | 6.84M | 10.63M | 0 | 0 | 27.96M | 12.1M | 40.15M | 36.02M |
| Total Non-Current Assets | 78.16M | 220.95M | 668.15M | 996.14M | 1.01B | 16.7B | 16.51B | 3.42B | 2.9B | 1.85B |
| Property, Plant & Equipment | 6.26M | 7.48M | 8.96M | 10.15M | 36.75M | 75.2M | 74.01M | 71.47M | 72.09M | 56.58M |
| Fixed Asset Turnover | 12.36x | 16.47x | 26.03x | 41.18x | 15.06x | 14.55x | 27.46x | 33.68x | 36.10x | 45.42x |
| Goodwill | 56.34M | 188.18M | 498.52M | 737.2M | 746.08M | 14.58B | 14.5B | 1.07B | 1.07B | 283.19M |
| Intangible Assets | 15.27M | 24.88M | 159.81M | 247.39M | 225.45M | 2.02B | 1.91B | 1.84B | 1.68B | 1.43B |
| Long-Term Investments | 0 | 0 | 49.4M | 94.01M | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Assets | 293K | 415K | 858K | 1.4M | 6.54M | 18.36M | 20.7M | 78.5M | 80.26M | 81.49M |
| Total Assets | 229.74M | 303.67M | 824.39M | 1.53B | 1.6B | 17.76B | 17.73B | 4.7B | 4.39B | 3.52B |
| Asset Turnover | 0.34x | 0.41x | 0.28x | 0.27x | 0.35x | 0.06x | 0.11x | 0.51x | 0.59x | 0.73x |
| Asset Growth % | 1.5% | 0.32% | 1.71% | 0.85% | 0.05% | 10.08% | -0% | -0.73% | -0.07% | -0.2% |
| Total Current Liabilities | 17.99M | 21.07M | 40.33M | 62.44M | 90.18M | 332.65M | 331.01M | 399.77M | 420.62M | 941.53M |
| Accounts Payable | 2.21M | 2.24M | 3.88M | 7.77M | 9.07M | 46.03M | 47.26M | 47.69M | 43.64M | 33.13M |
| Days Payables Outstanding | 38.39 | 25.53 | 23.01 | 22.03 | 17.96 | 42.99 | 26.53 | 23.4 | 20.96 | 16.1 |
| Short-Term Debt | 1.25M | 2M | 0 | 0 | 0 | 42.56M | 0 | 13.59M | 0 | 550.72M |
| Deferred Revenue (Current) | 831K | 1000K | 1000K | 1000K | 1000K | 1000K | 1000K | 1000K | 1000K | 1000K |
| Other Current Liabilities | 5.52M | 5.93M | 12.05M | 16.54M | 39.26M | 128.92M | 132.21M | 151.28M | 167.26M | 69.33M |
| Current Ratio | 8.43x | 3.93x | 3.87x | 8.53x | 6.52x | 3.19x | 3.70x | 3.22x | 3.54x | 1.77x |
| Quick Ratio | 8.43x | 3.93x | 3.87x | 8.53x | 6.52x | 3.02x | 3.48x | 3.07x | 3.47x | 1.73x |
| Cash Conversion Cycle | - | - | - | - | - | 66.26 | 48.63 | 39.98 | 25.48 | 34.25 |
| Total Non-Current Liabilities | 33.19M | 51.73M | 225.16M | 453.32M | 498.62M | 1.54B | 1.36B | 1.99B | 1.65B | 1.08B |
| Long-Term Debt | 25.23M | 42.42M | 207.37M | 414.68M | 440.41M | 1.38B | 1.23B | 1.54B | 1.54B | 991.42M |
| Capital Lease Obligations | 0 | 0 | 0 | 0 | 24.99M | 43.14M | 41.77M | 38.04M | 42.84M | 32.13M |
| Deferred Tax Liabilities | 1.19M | 1.69M | 12.91M | 32.44M | 21.68M | 102.1M | 75.78M | 406.54M | 49.45M | 49.85M |
| Other Non-Current Liabilities | 6.78M | 7.61M | 17.79M | 6.19M | 9.24M | 11.54M | 10.78M | 1.62M | 1.08M | 720K |
| Total Liabilities | 51.17M | 72.8M | 265.49M | 515.76M | 588.8M | 1.87B | 1.69B | 2.39B | 2.07B | 2.03B |
| Total Debt | 26.48M | 44.42M | 207.37M | 414.68M | 470.49M | 1.48B | 1.28B | 1.59B | 1.59B | 1.58B |
| Net Debt | -28.59M | -5.59M | 164.55M | -9.31M | -43.86M | 743.41M | 386.65M | 668.74M | 468.6M | 286.29M |
| Debt / Equity | 0.15x | 0.19x | 0.37x | 0.41x | 0.46x | 0.09x | 0.08x | 0.69x | 0.68x | 1.06x |
| Debt / EBITDA | - | - | - | - | - | - | - | - | 286.33x | - |
| Net Debt / EBITDA | - | - | - | - | - | - | - | - | 84.27x | - |
| Interest Coverage | -25.37x | -24.21x | -4.31x | -2.71x | -2.74x | -8.45x | -3.27x | -622.18x | -11.15x | -42.89x |
| Total Equity | 178.56M | 230.87M | 558.9M | 1.01B | 1.01B | 15.88B | 16.05B | 2.31B | 2.33B | 1.49B |
| Equity Growth % | 2.35% | 0.29% | 1.42% | 0.81% | 0% | 14.66% | 0.01% | -0.86% | 0.01% | -0.36% |
| Book Value per Share | 8.97 | 5.45 | 10.08 | 15.39 | 14.11 | 175.49 | 102.24 | 14.29 | 14.13 | 8.74 |
| Total Shareholders' Equity | 178.56M | 230.87M | 558.9M | 1.01B | 1.01B | 15.88B | 16.05B | 2.31B | 2.33B | 1.49B |
| Common Stock | 38K | 46K | 61K | 70K | 73K | 150K | 160K | 163K | 167K | 173K |
| Retained Earnings | -130.51M | -204.73M | -311.58M | -408.66M | -507.52M | -992.66M | -1.42B | -15.01B | -15.23B | -16.23B |
| Treasury Stock | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Accumulated OCI | -42K | -1K | 4.09M | -13.07M | -17.24M | 18.52M | -6.29M | -42.78M | -36.99M | -38.39M |
| Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Dec 2015 | Dec 2016 | Dec 2017 | Dec 2018 | Dec 2019 | Dec 2020 | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash from Operations | -47.18M | -51.8M | -34.44M | -4.86M | 29.87M | -53.51M | 193.99M | 189.29M | 350.02M | 293.68M |
| Operating CF Margin % | -0.61% | -0.42% | -0.15% | -0.01% | 0.05% | -0.05% | 0.1% | 0.08% | 0.13% | 0.11% |
| Operating CF Growth % | -3.15% | -0.1% | 0.34% | 0.86% | 7.15% | -2.79% | 4.63% | -0.02% | 0.85% | -0.16% |
| Net Income | -58.02M | -74.22M | -106.78M | -97.08M | -98.86M | -485.14M | -428.79M | -13.66B | -220.37M | -1B |
| Depreciation & Amortization | 4.86M | 8.27M | 19.09M | 35.6M | 44.95M | 78.09M | 219.62M | 270.64M | 348.72M | 382.84M |
| Stock-Based Compensation | 3.08M | 7.72M | 30.6M | 43.77M | 66.7M | 475.53M | 0 | 0 | 201.55M | 145.95M |
| Deferred Taxes | 36K | 510K | -306K | -2.25M | -10.87M | -90.16M | 41.8M | -7.84M | -1.9M | -1.15M |
| Other Non-Cash Items | 3.29M | 10.39M | 22.23M | 16.23M | 29.35M | 58.65M | 411.69M | 13.65B | 10.38M | 803.59M |
| Working Capital Changes | -427K | -4.47M | 720K | -1.13M | -1.4M | -90.48M | -50.32M | -60.97M | 11.64M | -36.31M |
| Change in Receivables | -6.79M | -2.9M | -3.66M | -10.93M | -15.88M | -21.09M | -17.51M | -61.64M | -10.25M | -375K |
| Change in Inventory | 4.09M | -2.45M | -923K | 1.71M | 0 | -24.73M | -19.49M | 14.8M | 24.09M | -9.75M |
| Change in Payables | -612K | -813K | 1.53M | -391K | 905K | -88M | 1.19M | 1.88M | -4.18M | -10.37M |
| Cash from Investing | -108.2M | 26.15M | -448.38M | -257.5M | 25.01M | -590.98M | -72.98M | -167.74M | -156.35M | -124.05M |
| Capital Expenditures | -7.82M | -3.41M | -5.51M | -8.41M | -3.51M | -26.04M | -63.93M | -172.76M | -156.35M | -10.79M |
| CapEx % of Revenue | 0.1% | 0.03% | 0.02% | 0.02% | 0.01% | 0.02% | 0.03% | 0.07% | 0.06% | 0% |
| Acquisitions | - | - | - | - | - | - | - | - | - | - |
| Investments | - | - | - | - | - | - | - | - | - | - |
| Other Investing | -84.16M | 65.27M | -66.39M | 5.53M | -7.39M | 0 | 8.71M | 2.51M | 1K | -113.26M |
| Cash from Financing | 164.01M | 20.6M | 475.43M | 645.61M | 35.09M | 859.14M | 40.95M | 6.5M | 10.85M | 8.31M |
| Debt Issued (Net) | - | - | - | - | - | - | - | - | - | - |
| Equity Issued (Net) | - | - | - | - | - | - | - | - | - | - |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Share Repurchases | - | - | - | - | - | - | - | - | - | - |
| Other Financing | 428K | 2.52M | 12.92M | 35.61M | 35.09M | 97.29M | -730K | -2.74M | 10.85M | -2K |
| Net Change in Cash | - | - | - | - | - | - | - | - | - | - |
| Free Cash Flow | -55M | -55.21M | -39.96M | -13.27M | 18.97M | -79.55M | 185.46M | 172.81M | 193.67M | 282.89M |
| FCF Margin % | -0.71% | -0.45% | -0.17% | -0.03% | 0.03% | -0.07% | 0.09% | 0.07% | 0.07% | 0.11% |
| FCF Growth % | -3.2% | -0% | 0.28% | 0.67% | 2.43% | -5.19% | 3.33% | -0.07% | 0.12% | 0.46% |
| FCF per Share | -2.76 | -1.30 | -0.72 | -0.20 | 0.26 | -0.88 | 1.18 | 1.07 | 1.18 | 1.66 |
| FCF Conversion (FCF/Net Income) | 0.81x | 0.70x | 0.32x | 0.05x | -0.30x | 0.11x | -0.45x | -0.01x | -1.59x | -0.29x |
| Interest Paid | 0 | 0 | 9.45M | 10.3M | 12.22M | 14.89M | 0 | 0 | 17.42M | 17.32M |
| Taxes Paid | 0 | 0 | 137K | 441K | 1.31M | 1.32M | 0 | 0 | 7.24M | 8.95M |
| Metric | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|
| Return on Equity (ROE) | -50.06% | -36.25% | -27.04% | -12.35% | -9.75% | -5.74% | -2.69% | -148.85% | -9.51% | -52.46% |
| Return on Invested Capital (ROIC) | -45.78% | -25.05% | -11.92% | -6.15% | -6.11% | -4.32% | -1.21% | -105.52% | -6.46% | -33.49% |
| Gross Margin | 72.81% | 74.04% | 73.58% | 69.2% | 66.66% | 64.27% | 68.01% | 69.09% | 70.8% | 70.76% |
| Net Margin | -74.98% | -60.26% | -45.77% | -23.23% | -17.87% | -44.35% | -21.09% | -567.53% | -8.47% | -38.97% |
| Debt / Equity | 0.15x | 0.19x | 0.37x | 0.41x | 0.46x | 0.09x | 0.08x | 0.69x | 0.68x | 1.06x |
| Interest Coverage | -25.37x | -24.21x | -4.31x | -2.71x | -2.74x | -8.45x | -3.27x | -622.18x | -11.15x | -42.89x |
| FCF Conversion | 0.81x | 0.70x | 0.32x | 0.05x | -0.30x | 0.11x | -0.45x | -0.01x | -1.59x | -0.29x |
| Revenue Growth | 77.78% | 59.15% | 89.42% | 79.14% | 32.4% | 97.71% | 85.81% | 18.41% | 8.13% | -1.26% |
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Other | - | - | - | - | - | - | - | - | - | 354.35M |
| Other Growth | - | - | - | - | - | - | - | - | - | - |
| Other.. | - | - | - | - | - | - | - | 303.03M | 319.89M | - |
| Other.. Growth | - | - | - | - | - | - | - | - | 5.57% | - |
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| UNITED STATES | - | - | - | - | - | - | - | - | 2.24B | 2.16B |
| UNITED STATES Growth | - | - | - | - | - | - | - | - | - | -3.47% |
| Non-US | - | - | - | - | - | - | - | - | 364.88M | 409.62M |
| Non-US Growth | - | - | - | - | - | - | - | - | - | 12.26% |
| United States | - | - | - | - | - | - | 241.51M | 2.1B | - | - |
| United States Growth | - | - | - | - | - | - | - | 769.93% | - | - |
| Other | - | - | - | - | - | - | - | 305.8M | - | - |
| Other Growth | - | - | - | - | - | - | - | - | - | - |
| Foreign. | - | - | - | - | - | - | 12.72M | - | - | - |
| Foreign. Growth | - | - | - | - | - | - | - | - | - | - |
| U | - | - | 214.5M | 342.7M | 19.93M | 206.09M | - | - | - | - |
| U Growth | - | - | - | 59.77% | -94.18% | 934.03% | - | - | - | - |
| Non Us | - | - | 18.8M | 75.2M | 106.64M | 818K | - | - | - | - |
| Non Us Growth | - | - | - | 300.00% | 41.81% | -99.23% | - | - | - | - |
| T | 12.6M | 15.1M | - | - | - | - | - | - | - | - |
| T Growth | - | 19.84% | - | - | - | - | - | - | - | - |
Teladoc Health, Inc. (TDOC) reported $2.53B in revenue for fiscal year 2024. This represents a 12601% increase from $19.9M in 2013.
Teladoc Health, Inc. (TDOC) saw revenue decline by 1.3% over the past year.
Teladoc Health, Inc. (TDOC) reported a net loss of $223.6M for fiscal year 2024.
Teladoc Health, Inc. (TDOC) has a return on equity (ROE) of -52.5%. Negative ROE indicates the company is unprofitable.
Teladoc Health, Inc. (TDOC) generated $198.7M in free cash flow for fiscal year 2024. Positive FCF indicates the company can fund dividends, buybacks, or reinvestment.